NCT05822830 A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities Status COMPLETED Phase PHASE3
NCT05821959 Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss Status RECRUITING Phase PHASE1/PHASE2
NCT05810597 A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices Status COMPLETED Phase PHASE1
NCT05803421 A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk Status COMPLETED Phase PHASE3
NCT05794243 A Multiple-Dose Study of LY3493269 in Healthy Participants Status TERMINATED Phase PHASE1
NCT05784246 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis Status RECRUITING Phase PHASE3
NCT05780268 LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) Status COMPLETED Phase PHASE3
NCT05778864 A Study of LY3473329 in Participants With Impaired and Normal Renal Function Status COMPLETED Phase PHASE1
NCT05768139 First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05767021 A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05757531 A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT05749848 A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT05738486 A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05735483 A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05734690 COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure Status COMPLETED Phase PHASE4
NCT05734495 Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05723198 A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata Status RECRUITING Phase PHASE3
NCT05714072 A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis Status RECRUITING Phase PHASE1
NCT05708859 Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT Status RECRUITING Phase PHASE4